Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Orfi

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Acta Pharmaceutica Hungarica|February 28, 2002
[Torrey Pines Institute for molecular studies]L Orfi
Acta Pharmaceutica Hungarica|July 1, 1995
[Synthesis of potential CCK antagonist quinazolone derivatives]M Szabó, J Kökösi, L Orfi
Analytical Chemistry|June 8, 2011
Measurement of SDS Micelle-Peptide Association Using (1)H NMR Chemical Shift Analysis and Pulsed-Field Gradient NMR SpectroscopyL Orfi, M Lin, C K Larive
Acta Crystallographica. Section C, Crystal Structure Communications|April 15, 1995
Two antithrombotic quinazolone derivativesZ Böcskei, K Simon, L Orfi, et al.
Lipids|November 14, 1997
Physicochemical characterization of psychosine by 1H nuclear magnetic resonance and electron microscopyL Orfi, C K Larive, S M LeVine
Acta Pharmaceutica Hungarica|September 1, 1995
[Synthesis of potential CCK antagonist quinazolone derivatives. II]M Szabó, A Kökösi, A Kovács, et al.
Fogorvosi Szemle|March 1, 1988
[Conditions of the routine use of chlorhexidine preparations in periodontics and oral surgery]F Dóri, I Gera, E Benedek, et al.
Acta Pharmaceutica Hungarica|March 1, 1991
[HPLC-investigations of imidazoquinazolone derivatives. Part 2]G Szász, Z Budváriné-Bárány, A Löre, et al.
Current Medicinal Chemistry|October 9, 2002
Reliability of logP predictions based on calculated molecular descriptors: a critical reviewD Eros, I Kövesdi, L Orfi, et al.
Bioorganic & Medicinal Chemistry|April 1, 1996
Heterocondensed quinazolones: synthesis and protein-tyrosine kinase inhibitory activity of 3,4-dihydro-1H,6H-[1,4] oxazino-[3,4-b]quinazolin-6-one derivativesL Orfi, J Kökösi, G Szász, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Acta Pharmaceutica Hungarica|February 28, 2002
[Torrey Pines Institute for molecular studies]L Orfi
Acta Pharmaceutica Hungarica|July 1, 1995
[Synthesis of potential CCK antagonist quinazolone derivatives]M Szabó, J Kökösi, L Orfi
Analytical Chemistry|June 8, 2011
Measurement of SDS Micelle-Peptide Association Using (1)H NMR Chemical Shift Analysis and Pulsed-Field Gradient NMR SpectroscopyL Orfi, M Lin, C K Larive
Acta Crystallographica. Section C, Crystal Structure Communications|April 15, 1995
Two antithrombotic quinazolone derivativesZ Böcskei, K Simon, L Orfi, et al.
Lipids|November 14, 1997
Physicochemical characterization of psychosine by 1H nuclear magnetic resonance and electron microscopyL Orfi, C K Larive, S M LeVine
Acta Pharmaceutica Hungarica|September 1, 1995
[Synthesis of potential CCK antagonist quinazolone derivatives. II]M Szabó, A Kökösi, A Kovács, et al.
Fogorvosi Szemle|March 1, 1988
[Conditions of the routine use of chlorhexidine preparations in periodontics and oral surgery]F Dóri, I Gera, E Benedek, et al.
Acta Pharmaceutica Hungarica|March 1, 1991
[HPLC-investigations of imidazoquinazolone derivatives. Part 2]G Szász, Z Budváriné-Bárány, A Löre, et al.
Current Medicinal Chemistry|October 9, 2002
Reliability of logP predictions based on calculated molecular descriptors: a critical reviewD Eros, I Kövesdi, L Orfi, et al.
Bioorganic & Medicinal Chemistry|April 1, 1996
Heterocondensed quinazolones: synthesis and protein-tyrosine kinase inhibitory activity of 3,4-dihydro-1H,6H-[1,4] oxazino-[3,4-b]quinazolin-6-one derivativesL Orfi, J Kökösi, G Szász, et al.
Pageof 3